ARTICLE | Company News
Jasco Pharmaceuticals, Roswell Park Cancer Institute deal
June 10, 2013 7:00 AM UTC
Jasco and Roswell Park partnered to jointly conduct preclinical testing of Jasco's cancer compound JP-11646, including pharmacokinetic and pharmacodynamics analysis. The project will utilize Roswell ...